Bain Capital Life Sciences Investors, LLC
Source: SEC Form 13F · as of Mar 2026Bain Capital Life Sciences Investors, LLC holds 12 biotech & pharma companies tracked by BioSniper, totaling $740.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$740.7M
BioSniper AIPage evidence connected
Prepared research question
What matters most for NEWAMSTERDAM PHARMA CO N.V. (NAMS)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 7,306,566 | $233.9M |
| OLMAOlema Pharmaceuticals, Inc. | 7,473,238 | $111.4M |
| SVRASavara Inc | 17,600,621 | $96.1M |
| PHVSPharvaris N.V. | 2,675,509 | $75.6M |
| SLDBSolid Biosciences Inc. | 9,808,819 | $70.6M |
| XFORX4 Pharmaceuticals, Inc | 7,967,454 | $32.9M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 362,470 | $30.4M |
| ANNXAnnexon, Inc. | 5,212,674 | $28.9M |
| CNTACentessa Pharmaceuticals plc | 635,000 | $25.2M |
| CCCCC4 Therapeutics, Inc. | 7,171,910 | $18.9M |
| IRONDisc Medicine, Inc. | 141,234 | $9.0M |
| UPBUpstream Bio, Inc. | 867,211 | $7.8M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.